SEC Form 4 · accession 0001104659-18-039182
RHYTHM PHARMACEUTICALS, INC. · RYTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Simon Kelner
Officer — Chief Human Resources Officer
Period of report
Jun 6, 2018
Accepted (ET)
Jun 8, 2018 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649904
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $34.89 | Jun 6, 2018 | A | 60,000 | A | — | Jun 5, 2028 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1The option vests as follows: (1) 25% on June 4, 2019, and (2) the remaining 75% in 12 equal quarterly installments.